Skip to content
10-Q

Quarterly Report

Unicycive Therapeutics, Inc. UNCY

0001213900-25-076007

← back to feed
Filed
Aug 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 14, 2025 17.66M sh
Shares Diluted Q2 2025 · Jun 30, 2025 12.3M sh
Shares Diluted Q2 2025 · Jun 30, 2025 11.99M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 9.41M sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 3.64M sh
Capex Q2 2025 · Jun 30, 2025 $22K
Capex Q2 2025 · Jun 30, 2024 $26K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$17.32M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$12.78M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $22.33M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $26.14M
Stockholders Equity Q2 2025 · Jun 30, 2025 $16.43M
Stockholders Equity Q2 2025 · Mar 31, 2025 $11.27M
Stockholders Equity Q2 2025 · Dec 31, 2024 $7.43M
Stockholders Equity Q2 2025 · Jun 30, 2024 −$14.85M
Stockholders Equity Q2 2025 · Mar 31, 2024 −$24.46M
Stockholders Equity Q2 2025 · Dec 31, 2023 −$3.81M
Current Liabilities Q2 2025 · Jun 30, 2025 $13.57M
Current Liabilities Q2 2025 · Dec 31, 2024 $24.12M
Total Liabilities Q2 2025 · Jun 30, 2025 $13.57M
Total Liabilities Q2 2025 · Dec 31, 2024 $24.24M
Current Assets Q2 2025 · Jun 30, 2025 $29.53M
Current Assets Q2 2025 · Dec 31, 2024 $30.95M
Total Assets Q2 2025 · Jun 30, 2025 $30M
Total Assets Q2 2025 · Dec 31, 2024 $31.67M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.52
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.49
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$1.50
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$3.35
Eps Basic Q2 2025 · Jun 30, 2025 −$0.52
Eps Basic Q2 2025 · Jun 30, 2025 −$0.49
Eps Basic restated Q2 2025 · Jun 30, 2024 $0.80
Eps Basic restated Q2 2025 · Jun 30, 2024 −$3.35
Rd Expense Q2 2025 · Jun 30, 2025 $1.75M
Rd Expense Q2 2025 · Jun 30, 2025 $3.94M
Rd Expense Q2 2025 · Jun 30, 2024 $4.87M
Rd Expense Q2 2025 · Jun 30, 2024 $11.68M
Net Income Q2 2025 · Jun 30, 2025 −$6.45M
Net Income Q2 2025 · Jun 30, 2025 −$5.88M
Net Income Q2 2025 · Mar 31, 2025 $570K
Net Income Q2 2025 · Jun 30, 2024 $9.86M
Net Income Q2 2025 · Jun 30, 2024 −$11.11M
Net Income Q2 2025 · Mar 31, 2024 −$20.96M
Operating Income Q2 2025 · Jun 30, 2025 −$6.96M
Operating Income Q2 2025 · Jun 30, 2025 −$14.97M
Operating Income Q2 2025 · Jun 30, 2024 −$7.4M
Operating Income Q2 2025 · Jun 30, 2024 −$16.61M
Dividends Paid Q2 2025 · Jun 30, 2024 $1.1M